Geode Capital Management’s Unicycive Therapeutics UNCY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $280K | Sell |
58,786
-520,416
| -90% | -$2.48M | ﹤0.01% | 3763 |
|
2025
Q1 | $333K | Buy |
579,202
+54,715
| +10% | +$31.5K | ﹤0.01% | 3685 |
|
2024
Q4 | $417K | Buy |
524,487
+122,089
| +30% | +$97K | ﹤0.01% | 3668 |
|
2024
Q3 | $164K | Buy |
402,398
+116,660
| +41% | +$47.6K | ﹤0.01% | 3967 |
|
2024
Q2 | $143K | Buy |
285,738
+32,545
| +13% | +$16.3K | ﹤0.01% | 4026 |
|
2024
Q1 | $349K | Buy |
253,193
+84,061
| +50% | +$116K | ﹤0.01% | 3742 |
|
2023
Q4 | $147K | Buy |
169,132
+116,733
| +223% | +$101K | ﹤0.01% | 4051 |
|
2023
Q3 | $45.1K | Sell |
52,399
-14,353
| -22% | -$12.3K | ﹤0.01% | 4443 |
|
2023
Q2 | $85.4K | Sell |
66,752
-29,146
| -30% | -$37.3K | ﹤0.01% | 4386 |
|
2023
Q1 | $201K | Buy |
95,898
+69,789
| +267% | +$147K | ﹤0.01% | 4048 |
|
2022
Q4 | $13K | Hold |
26,109
| – | – | ﹤0.01% | 4821 |
|
2022
Q3 | $15K | Hold |
26,109
| – | – | ﹤0.01% | 4948 |
|
2022
Q2 | $21K | Hold |
26,109
| – | – | ﹤0.01% | 4917 |
|
2022
Q1 | $33K | Hold |
26,109
| – | – | ﹤0.01% | 4887 |
|
2021
Q4 | $53K | Hold |
26,109
| – | – | ﹤0.01% | 4851 |
|
2021
Q3 | $73K | Buy |
+26,109
| New | +$73K | ﹤0.01% | 4728 |
|